Polestar Technologies, a well-known innovative sensing technology and sensor system provider, has launched a new oxygen (O2) sensor for the regenerative medicine market.
The sensor could measure O2 levels from samples, which have less than 1% or up to 100% purity of oxygen in them. This would give researchers and scientists the capacity to measure a broad range of O2 levels.
These precise oxygen sensors could also be used in any application where measurement of extremely high levels of O2 are needed such as tissue engineering or regenerative medicine where very high levels of O2 are needed for promoting a healthy growth of tissue. The flow cells, when equipped with the new O2 sensors, prove to be an ideal device for measurement of input and output oxygen levels as a method of finding out the oxygen consumed by the tissue. This configuration is already being used by Harvard Apparatus, a partner of Polestar Technologies.
Its accuracy levels are more than 0.4% at 90% of O2. Upon standardization, the sensing accuracy shows improvement and achieves better than 0.3% at 90% O2. Moreover, the response time taken by this sensor is the fastest achieved by any sensor so far, thereby when the user changes the O2 levels the sensor within 15 seconds would be able to give the true reading within 10%.
Rusty Warren, Polestar’s President of the Products Division, revealed that the sensor would be of immense help to researchers. Just like other sensors developed by Polestar, these oxygen sensors could also be sterilized by steam, autoclave or gamma radiation. They are made from USP class VI certified materials and are capable of withstanding or enduring temperatures between 0oC and 60o C along with temperature condensation. They are also compatible with the DSP4000 monitor developed by Polestar.